Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CTP Newsroom

CTP Newsroom

                        Feature Stories Home
          Tobacco Products
          CTP Newsroom
          FDA Revises Two Guidances to Reflect Updated Agency TerminologyCTP Newsroom FDA Revises Two Guidances to Reflect Updated Agency Terminology
  
  	
    Share
    Post
    Linkedin

    Email
    PrintOn Oct. 17, FDA released two revised final guidances to reflect updated terminology:

“Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions”
	“Establishing That a Tobacco Product Was Commercially Marketed in the United States as of February 15, 2007”In August 2022, FDA updated the term “grandfathered tobacco product” to “pre-existing tobacco product” on all the Center’s systems because it more clearly and appropriately describes these products. Additionally, the term “grandfathered” – when used to describe someone or something exempt from a new law or regulation – has its roots in 19th century racist voting laws, and updating the term reflects CTP’s commitment to diversity, equity, inclusion, and accessibility.

A “pre-existing tobacco product” has the same definition as a grandfathered product: specifically, FDA considers a pre-existing tobacco product to mean a tobacco product that was commercially marketed in the United States as of Feb. 15, 2007.

FDA also made other minor changes to the revised guidance documents to reflect additional updated terminology used in the substantial equivalence final rule, when appropriate. Details on these minor changes are described in the document history page included with each guidance; in brief, they relate to replacing the term “grandfathered” with “pre-existing tobacco product” and editorial changes to promote consistency throughout FDA’s guidances.

Additionally, FDA is also announcing the withdrawal of two final guidances and a draft guidance that are no longer needed:

Final guidance: “Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products”
	Final guidance: “Investigational Use of Deemed, Finished Tobacco Products That Were on the U.S. Market on August 8, 2016, During the Deeming Compliance Periods”
	Draft guidance: “Substantial Equivalence Reports: Manufacturer Requests for Extensions or to Change the Predicate Tobacco Product”FDA withdrew these guidances because they are now obsolete due to the issuance of the substantial equivalence final rule, or the end of the compliance period for deemed, finished tobacco products that were on the U.S. market on Aug. 8, 2016.

Read the Revised Guidances

                                                                                  Content current as of:
      10/17/2023CTP Newsroom

          
                        Feature Stories
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop